GEODE CAPITAL MANAGEMENT, LLC - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314507. A total of 27 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q3 2020$85,000
-46.2%
516,1630.0%0.00%
Q2 2020$158,000
+53.4%
516,163
+16.3%
0.00%
Q1 2020$103,000
+221.9%
443,680
+168.4%
0.00%
Q4 2019$32,000
+45.5%
165,328
+100.0%
0.00%
Q3 2019$22,000
-79.0%
82,6640.0%0.00%
Q2 2019$105,000
+4.0%
82,664
+45.2%
0.00%
Q1 2019$101,000
-33.6%
56,913
-91.7%
0.00%
Q4 2018$152,000682,9480.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2020
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 23,370$30,0000.01%
A.R.T. Advisors, LLC 69,645$89,0000.01%
Virtu Financial LLC 39,318$50,0000.00%
Blume Capital Management, Inc. 425$1,0000.00%
VANGUARD GROUP INC 582,180$746,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 35$00.00%
UBS Group AG 1,975$2,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1$1,0000.00%
Advisor Group, Inc. 350$00.00%
BANK OF AMERICA CORP /DE/ 6,125$8,0000.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders